1. Home
  2. CUE vs DUOT Comparison

CUE vs DUOT Comparison

Compare CUE & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • DUOT
  • Stock Information
  • Founded
  • CUE 2014
  • DUOT 1990
  • Country
  • CUE United States
  • DUOT United States
  • Employees
  • CUE N/A
  • DUOT N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • CUE Health Care
  • DUOT Technology
  • Exchange
  • CUE Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • CUE 60.6M
  • DUOT 66.3M
  • IPO Year
  • CUE 2018
  • DUOT N/A
  • Fundamental
  • Price
  • CUE $0.76
  • DUOT $5.75
  • Analyst Decision
  • CUE Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • CUE 3
  • DUOT 2
  • Target Price
  • CUE $3.00
  • DUOT $10.75
  • AVG Volume (30 Days)
  • CUE 206.6K
  • DUOT 105.7K
  • Earning Date
  • CUE 05-08-2025
  • DUOT 05-12-2025
  • Dividend Yield
  • CUE N/A
  • DUOT N/A
  • EPS Growth
  • CUE N/A
  • DUOT N/A
  • EPS
  • CUE N/A
  • DUOT N/A
  • Revenue
  • CUE $9,287,000.00
  • DUOT $7,280,885.00
  • Revenue This Year
  • CUE N/A
  • DUOT $240.43
  • Revenue Next Year
  • CUE $4.77
  • DUOT $89.30
  • P/E Ratio
  • CUE N/A
  • DUOT N/A
  • Revenue Growth
  • CUE 69.16
  • DUOT N/A
  • 52 Week Low
  • CUE $0.45
  • DUOT $2.03
  • 52 Week High
  • CUE $2.26
  • DUOT $8.53
  • Technical
  • Relative Strength Index (RSI)
  • CUE 39.49
  • DUOT 56.08
  • Support Level
  • CUE $0.72
  • DUOT $3.84
  • Resistance Level
  • CUE $0.89
  • DUOT $4.84
  • Average True Range (ATR)
  • CUE 0.10
  • DUOT 0.68
  • MACD
  • CUE 0.02
  • DUOT 0.11
  • Stochastic Oscillator
  • CUE 48.59
  • DUOT 76.08

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: